a<p>Data from a screen of 144 pharmacologic modulators are summarized to show compound classes and targets that regulated production of both IL-17A and IL-17F or had selectivity for IL-17A or IL-17F in BT co-cultures. The number of agents with selectivity for a specific target is shown in parentheses next to the total number of agents in the screen for that target. Class/targets were only included if greater than 50% of agents specific for a class/target had effects on IL-17A and/or IL-17F. Agents that inhibited both IL-17A and IL-17F, or preferentially inhibited IL-17A or IL-17F had readout values less than log<sub>10</sub> ratio −0.2 and were observed at 2 or more non-cytotoxic doses. *Agents against these targets selectively inhibited IL...
CD4+ T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathological T-hel...
<p>Non-toxic compounds that reduced the HMGB1-induced TNFα production by 2 standard deviation values...
<p>List of primary antibodies and other reagents utilized in the flow cytometry panel used to genera...
a<p>Data from the screen summarized to show compound targets that increased production of both IL-17...
<p>Profiles of BW 245C (0.37–10 μM; A), LPS (0.1–100 ng/ml; B), or HKLM (10–10,000 U/ml; C) added to...
<p>Profiles of Torin-1 (0.460–12.3 nM; A), CP-690,550 (0.041–1.11 μM; B), or Axitinib (0.333–9 μM; C...
IL-17a is a major inflammation target, with several approved antibodies in clinical use. Small-molec...
<div><p>CD4<sup>+</sup> T-helper cells that produce interleukin-17 (Th17 cells) are characterized as...
Improper regulation of B cell responses leads to excessive production of antibodies and contributes ...
Interleukin 17(A) is a pro-inflammatory cytokine involved in several auto-immune and inflammatory di...
Inhibiting the interleukin 17 pathway is of interest in a number of autoimmune diseases. Herein, 42 ...
<p>Profiles of erythromycin (3.3–90 μM; A) or wortmannin (1.5–13.7 nM; B) added to BT co-cultures st...
<p>A: Mouse Hepa1 cells that were transfected with luciferase reporter gene fused to the dioxin-resp...
CD4+ T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathologi-cal T-he...
<p><b>A</b>) Inhibition of IL-17 production by selected couples or cocktail of cytokine blocking ant...
CD4+ T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathological T-hel...
<p>Non-toxic compounds that reduced the HMGB1-induced TNFα production by 2 standard deviation values...
<p>List of primary antibodies and other reagents utilized in the flow cytometry panel used to genera...
a<p>Data from the screen summarized to show compound targets that increased production of both IL-17...
<p>Profiles of BW 245C (0.37–10 μM; A), LPS (0.1–100 ng/ml; B), or HKLM (10–10,000 U/ml; C) added to...
<p>Profiles of Torin-1 (0.460–12.3 nM; A), CP-690,550 (0.041–1.11 μM; B), or Axitinib (0.333–9 μM; C...
IL-17a is a major inflammation target, with several approved antibodies in clinical use. Small-molec...
<div><p>CD4<sup>+</sup> T-helper cells that produce interleukin-17 (Th17 cells) are characterized as...
Improper regulation of B cell responses leads to excessive production of antibodies and contributes ...
Interleukin 17(A) is a pro-inflammatory cytokine involved in several auto-immune and inflammatory di...
Inhibiting the interleukin 17 pathway is of interest in a number of autoimmune diseases. Herein, 42 ...
<p>Profiles of erythromycin (3.3–90 μM; A) or wortmannin (1.5–13.7 nM; B) added to BT co-cultures st...
<p>A: Mouse Hepa1 cells that were transfected with luciferase reporter gene fused to the dioxin-resp...
CD4+ T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathologi-cal T-he...
<p><b>A</b>) Inhibition of IL-17 production by selected couples or cocktail of cytokine blocking ant...
CD4+ T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathological T-hel...
<p>Non-toxic compounds that reduced the HMGB1-induced TNFα production by 2 standard deviation values...
<p>List of primary antibodies and other reagents utilized in the flow cytometry panel used to genera...